speb/financial-data huggingface dataset:
Financial ratios for CEMPRO.NS — quarterly report dated 2025-06-30
Total revenue: 297491820.7348467
Gross profit: 102740568.68710509
Operating income: 22440685.70091271
Net income: 16056166.627662065
Capital expenditures: 0
Depreciation & amortization: 4805148.607535689
Owner earnings: 20861315.235197753
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.879241750526562
P/E ratio: 47.36937974566643
Shares outstanding: 171787584
Market cap (USD): 1868918656.074889
Effective tax rate (%): 16.087629505912886
Interest coverage ratio: 3.8474429036865843
COGS to revenue (%): 65.46440556472398
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.48986449552109546
Rule of 40 score: 0.48986449552109546
Financial ratios for CEMPRO.NS — quarterly report dated 2025-12-31
Total revenue: 257934722.06750587
Gross profit: 71305558.64988303
Operating income: 19963239.389551077
Net income: 12352679.068731202
Capital expenditures: 0
Depreciation & amortization: 4755486.2426200295
Owner earnings: 17108165.311351232
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.759496491032639
P/E ratio: 29.045837014832916
Shares outstanding: 171787584
Market cap (USD): 1504772739.2509747
Effective tax rate (%): 27.10360241914278
Interest coverage ratio: 3.5763320694472163
COGS to revenue (%): 72.35519201202342
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -13.296869328921124
Rule of 40 score: -13.296869328921124
Financial ratios for COFS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.13
Shares outstanding: 14950472
Market cap (USD): 330853945.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COFS — annual report dated 2022-12-31
Total revenue: 81386000
Net income: 23640000
Capital expenditures: 1164000
Operating cash flow: 44327000
Depreciation & amortization: 13342000
Net tangible assets: 106119000
Owner earnings: 35818000
Return on net tangible assets (%): 33.752673884978186
Buffett classification: The Gruesome
Stock price: 25.32
P/E ratio: 16.012942091370558
Shares outstanding: 14950472
Book value: 168874000
P/B ratio: 2.24158811326788
Market cap (USD): 378545951.04
Debt to equity: 0.5048852990987364
Effective tax rate (%): 14.527442331332708
COGS to revenue (%): 0
SG&A to revenue (%): 39.16767011525324
Free cash flow (dilution-adjusted): 42205000
Buyback yield (%): 0.1801630682157091
Retained earnings: 68394000
Capitalized R&D asset: 0
FCF margin (%): 51.857813383137156
Rule of 40 score: 51.857813383137156
Financial ratios for COFS — annual report dated 2023-12-31
Total revenue: 80791000
Net income: 21261000
Capital expenditures: 4234000
Operating cash flow: 46333000
Depreciation & amortization: 12430000
Net tangible assets: 133834000
Owner earnings: 29457000
Return on net tangible assets (%): 22.010102066739393
Buffett classification: The Gruesome
Stock price: 26.66
P/E ratio: 18.74698196321904
Shares outstanding: 14950472
Book value: 195634000
P/B ratio: 2.0373737873784723
Market cap (USD): 398579583.52
Debt to equity: 1.2038142654139874
Effective tax rate (%): 16.842022920170532
COGS to revenue (%): 0
SG&A to revenue (%): 41.920510948001635
Free cash flow (dilution-adjusted): 41094000
Buyback yield (%): 0
Retained earnings: 73699000
Capitalized R&D asset: 0
FCF margin (%): 50.86457649985766
Revenue growth (%): -0.7310839702160077
Rule of 40 score: 50.13349252964166
Financial ratios for COFS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.97
Shares outstanding: 14950472
Market cap (USD): 433115173.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COFS — annual report dated 2024-12-31
Total revenue: 92437000
Net income: 26727000
Capital expenditures: 1706000
Operating cash flow: 47081000
Depreciation & amortization: 12333000
Net tangible assets: 199373000
Owner earnings: 37354000
Return on net tangible assets (%): 18.735736534034196
Buffett classification: The Gruesome
Stock price: 33.66
P/E ratio: 18.828633498709166
Shares outstanding: 14950472
Book value: 260415000
P/B ratio: 1.9324266556073955
Market cap (USD): 503232887.5199999
Debt to equity: 0.8092928594743006
Effective tax rate (%): 19.226933421983137
COGS to revenue (%): 0
SG&A to revenue (%): 38.438071335071456
Free cash flow (dilution-adjusted): 44655000
Buyback yield (%): 0
Retained earnings: 91414000
Capitalized R&D asset: 0
FCF margin (%): 48.308577734024254
Revenue growth (%): 14.414971964699038
Rule of 40 score: 62.72354969872329
Financial ratios for COFS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.66
Shares outstanding: 14950472
Market cap (USD): 503232887.5199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COFS — quarterly report dated 2025-03-31
Total revenue: 31233000
Net income: -13906000
Capital expenditures: 835000
Operating cash flow: -9393000
Depreciation & amortization: 3634000
Net tangible assets: 265185000
Owner earnings: -11107000
Return on net tangible assets (%): -4.188396779606689
Buffett classification: The Gruesome
Stock price: 27.44
Shares outstanding: 14950472
Book value: 427068000
P/B ratio: 0.9605986673784971
Market cap (USD): 410240951.68
Debt to equity: 0.43439452265213035
COGS to revenue (%): 0
SG&A to revenue (%): 35.318413216789935
Free cash flow (dilution-adjusted): -10418000
Buyback yield (%): 0.5019001617386263
Retained earnings: 73316000
Capitalized R&D asset: 0
FCF margin (%): -33.35574552556591
Rule of 40 score: -33.35574552556591
Financial ratios for COFS — quarterly report dated 2025-06-30
Total revenue: 42825000
Net income: 13534000
Capital expenditures: 2075000
Operating cash flow: 11879000
Depreciation & amortization: 5413000
Net tangible assets: 271610000
Owner earnings: 16872000
Return on net tangible assets (%): 6.211847870107875
Buffett classification: The Gruesome
Stock price: 27.63
P/E ratio: 7.6304407669572925
Shares outstanding: 14950472
Book value: 431761000
P/B ratio: 0.9567365773193965
Market cap (USD): 413081541.36
Debt to equity: 0.57139250650244
Effective tax rate (%): 18.807366968624393
COGS to revenue (%): 0
SG&A to revenue (%): 33.95446584938704
Free cash flow (dilution-adjusted): 9612000
Buyback yield (%): 0
Retained earnings: 82647000
Capitalized R&D asset: 0
FCF margin (%): 22.444833625218912
Revenue growth (%): 37.114590337143404
Rule of 40 score: 59.55942396236232
Financial ratios for COFS — quarterly report dated 2025-09-30
Total revenue: 44741000
Net income: 14681000
Capital expenditures: 1600000
Operating cash flow: 15294000
Depreciation & amortization: 5504000
Net tangible assets: 291191000
Owner earnings: 18585000
Return on net tangible assets (%): 6.382408796975181
Buffett classification: The Gruesome
Stock price: 28.14
P/E ratio: 29.401515275700607
Shares outstanding: 14950472
Book value: 449615000
P/B ratio: 0.935703395304872
Market cap (USD): 420706282.08
Debt to equity: 0.5479532488907176
Effective tax rate (%): 19.889774091454765
COGS to revenue (%): 0
SG&A to revenue (%): 33.222324042824255
Free cash flow (dilution-adjusted): 13452000
Buyback yield (%): 0
Retained earnings: 93124000
Capitalized R&D asset: 0
FCF margin (%): 30.066382065666836
Revenue growth (%): 4.474022183304145
Rule of 40 score: 34.54040424897098
Financial ratios for COFS — annual report dated 2025-12-31
Total revenue: 161736000
Net income: 28176000
Capital expenditures: 6627000
Operating cash flow: 31814000
Depreciation & amortization: 19870000
Net tangible assets: 307512000
Owner earnings: 41419000
Return on net tangible assets (%): 13.469067873774032
Buffett classification: The Gruesome
Stock price: 28.95
P/E ratio: 15.36116426746167
Shares outstanding: 14950472
Book value: 465353000
P/B ratio: 0.9300813885373039
Market cap (USD): 432816164.4
Debt to equity: 0.6735961732276358
Effective tax rate (%): 17.585117585117587
COGS to revenue (%): 0
SG&A to revenue (%): 34.45615076420834
Free cash flow (dilution-adjusted): 24304000
Buyback yield (%): 0.6189694887467563
Retained earnings: 102641000
Capitalized R&D asset: 0
FCF margin (%): 15.02695751100559
Revenue growth (%): 74.96889773575516
Rule of 40 score: 89.99585524676075
Financial ratios for COFS — quarterly report dated 2025-12-31
Total revenue: 42937000
Net income: 13867000
Capital expenditures: 2117000
Operating cash flow: 14034000
Depreciation & amortization: 5319000
Net tangible assets: 307512000
Owner earnings: 17069000
Return on net tangible assets (%): 5.550677697130518
Buffett classification: The Gruesome
Stock price: 28.95
P/E ratio: 15.36116426746167
Shares outstanding: 14950472
Book value: 465353000
P/B ratio: 0.9300813885373039
Market cap (USD): 432816164.4
Debt to equity: 0.6735961732276358
Effective tax rate (%): 17.399332856802477
COGS to revenue (%): 0
SG&A to revenue (%): 35.6149707711298
Free cash flow (dilution-adjusted): 11658000
Buyback yield (%): 0.1450962444691911
Retained earnings: 102641000
Capitalized R&D asset: 0
FCF margin (%): 27.151407876656496
Revenue growth (%): -4.032095840504236
Rule of 40 score: 23.11931203615226
Financial ratios for COHR — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.59
Shares outstanding: 195639321
Market cap (USD): 14201458311.390001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHR — annual report dated 2022-06-30
Total revenue: 3316616000
Gross profit: 1265496000
Operating income: 414294000
Net income: 234759000
Capital expenditures: 314332000
Operating cash flow: 413332000
Depreciation & amortization: 286779000
Net tangible assets: 2462115000
Owner earnings: 207206000
Return on net tangible assets (%): 8.41577261825707
Capex to operating income (%): 75.87172394483144
Buffett classification: The Gruesome
Stock price: 50.95
P/E ratio: 42.459813702350075
Shares outstanding: 195639321
Book value: 4383278000
P/B ratio: 2.2740568599459126
Market cap (USD): 9967823404.95
Debt to equity: 0.5562535618320353
Current ratio: 3.398051554943767
Quick ratio: 2.6856693863021612
Effective tax rate (%): 16.69511403194385
Interest coverage ratio: 3.4167450145974567
COGS to revenue (%): 61.843758819230196
R&D to revenue (%): 11.370203846330115
SG&A to revenue (%): 14.294570128106479
Free cash flow (dilution-adjusted): 25786000
Buyback yield (%): 0
Retained earnings: 1348125000
Inventory turnover: 2.2725605749873417
Receivables turnover: 4.60694858844643
Capitalized R&D asset: 377106000
ROCI (R&D-adjusted, %): 9.57151214961683
FCF margin (%): 0.7774792137528131
Rule of 40 score: 0.7774792137528131
Financial ratios for COHR — annual report dated 2023-06-30
Total revenue: 5160100000
Gross profit: 1618283000
Operating income: 81981000
Net income: -259458000
Capital expenditures: 436060000
Operating cash flow: 634025000
Depreciation & amortization: 681687000
Net tangible assets: -1098418000
Owner earnings: -13831000
Capex to operating income (%): 531.9037337919763
Buffett classification: The Gruesome
Stock price: 50.98
Shares outstanding: 195639321
Book value: 7228966000
P/B ratio: 1.3796845336635972
Market cap (USD): 9973692584.58
Debt to equity: 0.6209486944605909
Current ratio: 3.014603966820796
Quick ratio: 1.8351505634309404
Interest coverage ratio: 0.285775537521961
COGS to revenue (%): 68.63853413693532
R&D to revenue (%): 9.682041045716169
SG&A to revenue (%): 20.09067653727641
Free cash flow (dilution-adjusted): 49093000
Buyback yield (%): 0
Retained earnings: 944416000
Inventory turnover: 2.7837185705314567
Receivables turnover: 5.54967616761418
Capitalized R&D asset: 752264020
ROCI (R&D-adjusted, %): 2.1617874793303073
Rosenberg metric: 0.9355115007451485
FCF margin (%): 0.9513962907695588
Revenue growth (%): 55.58328127223652
Rule of 40 score: 56.53467756300608
Financial ratios for COHR — annual report dated 2024-06-30
Total revenue: 4707688000
Gross profit: 1455964000
Operating income: 123175000
Net income: -156154000
Capital expenditures: 346816000
Operating cash flow: 545731000
Depreciation & amortization: 559761000
Net tangible assets: -392689000
Owner earnings: 56791000
Capex to operating income (%): 281.56362898315405
Buffett classification: The Gruesome
Stock price: 72.46
Shares outstanding: 195639321
Book value: 7946279000
P/B ratio: 1.7839828175753705
Market cap (USD): 14176025199.659998
Debt to equity: 0.5415305704720411
Current ratio: 2.723760145918154
Quick ratio: 1.7664483500487809
Interest coverage ratio: 0.4269867406187711
COGS to revenue (%): 69.07263183116639
R&D to revenue (%): 10.170342639529213
SG&A to revenue (%): 18.140560716852942
Free cash flow (dilution-adjusted): 72866000
Buyback yield (%): 0
Retained earnings: 664940000
Inventory turnover: 2.527762662429532
Receivables turnover: 5.377443169292171
Capitalized R&D asset: 937966990
ROCI (R&D-adjusted, %): 1.0660543664242021
Rosenberg metric: -0.3248959673981141
FCF margin (%): 1.54780860583794
Revenue growth (%): -8.767504505726635
Rule of 40 score: -7.219695899888695
Financial ratios for COHR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.91
Shares outstanding: 195639321
Market cap (USD): 17394292030.11
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 94.73
Shares outstanding: 195639321
Market cap (USD): 18532912878.33
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHR — quarterly report dated 2025-03-31
Total revenue: 1497879000
Gross profit: 527690000
Operating income: 145520000
Net income: 15711000
Capital expenditures: 111819000
Operating cash flow: 162957000
Depreciation & amortization: 146570000
Net tangible assets: 73705000
Owner earnings: 50462000
Return on net tangible assets (%): 68.46482599552269
Capex to operating income (%): 76.84098405717427
Buffett classification: The Gruesome
Stock price: 64.94
P/E ratio: 202.16436741359556
Shares outstanding: 195639321
Book value: 8168789000
P/B ratio: 1.5552877551054385
Market cap (USD): 12704817505.74
Debt to equity: 0.48287757218358807
Current ratio: 2.471507758162303
Quick ratio: 1.54196782373327
Effective tax rate (%): 82.15369059656219
Interest coverage ratio: 2.5403253962712102
COGS to revenue (%): 64.77085265231705
R&D to revenue (%): 10.062962362113362
SG&A to revenue (%): 15.451114542629945
Free cash flow (dilution-adjusted): 10178000
Buyback yield (%): 0
Retained earnings: 713135000
Inventory turnover: 0.697212770162232
Receivables turnover: 1.4473099889848686
Capitalized R&D asset: 150731000
ROCI (R&D-adjusted, %): 1.8781261725214615
FCF margin (%): 0.6794941380445283
Rule of 40 score: 0.6794941380445283
Financial ratios for COHR — annual report dated 2025-06-30
Total revenue: 5810115000
Gross profit: 2043322000
Operating income: 534947000
Net income: 49364000
Capital expenditures: 440836000
Operating cash flow: 633600000
Depreciation & amortization: 553598000
Net tangible assets: 451944000
Owner earnings: 162126000
Return on net tangible assets (%): 35.873028516807395
Capex to operating income (%): 82.40741606177808
Buffett classification: The Gruesome
Stock price: 89.21
P/E ratio: 353.55692055769384
Shares outstanding: 195639321
Book value: 8481283000
P/B ratio: 2.0578235423119353
Market cap (USD): 17452983826.41
Debt to equity: 0.45908832425471474
Current ratio: 2.188023340229023
Quick ratio: 1.3870409690886267
Effective tax rate (%): 68.08591966532528
Interest coverage ratio: 2.199156426900609
COGS to revenue (%): 64.83164274717454
R&D to revenue (%): 10.01570536899872
SG&A to revenue (%): 15.945484727927074
Free cash flow (dilution-adjusted): 32525000
Buyback yield (%): 0
Retained earnings: 584374000
Inventory turnover: 2.620129852062692
Receivables turnover: 5.697174218296491
Capitalized R&D asset: 1067580950
ROCI (R&D-adjusted, %): 4.207414228185325
Rosenberg metric: 1.226760069174666
FCF margin (%): 0.5597995908858947
Revenue growth (%): 23.417588421322737
Rule of 40 score: 23.977388012208632
Financial ratios for COHR — quarterly report dated 2025-06-30
Total revenue: 1529436000
Gross profit: 546149000
Operating income: 144978000
Net income: -95619000
Capital expenditures: 131350000
Operating cash flow: 130284000
Depreciation & amortization: 134823000
Net tangible assets: 451944000
Owner earnings: -92146000
Return on net tangible assets (%): -20.38880923300232
Capex to operating income (%): 90.59995309633186
Buffett classification: The Gruesome
Stock price: 89.21
Shares outstanding: 195639321
Book value: 8481283000
P/B ratio: 2.0578235423119353
Market cap (USD): 17452983826.41
Debt to equity: 0.45908832425471474
Current ratio: 2.188023340229023
Quick ratio: 1.3870409690886267
Interest coverage ratio: 2.6338087019711147
COGS to revenue (%): 64.29082354541151
R&D to revenue (%): 10.182773257592995
SG&A to revenue (%): 16.047222636318224
Free cash flow (dilution-adjusted): -44656000
Buyback yield (%): 0
Retained earnings: 584374000
Inventory turnover: 0.6839610304694651
Receivables turnover: 1.4997058315944711
Capitalized R&D asset: 256728770
ROCI (R&D-adjusted, %): 1.4848048306654185
Rosenberg metric: 0.12246319602470626
FCF margin (%): -2.9197691175047535
Revenue growth (%): 2.106778985485476
Rule of 40 score: -0.8129901320192774
Financial ratios for COHR — quarterly report dated 2025-09-30
Total revenue: 1581378000
Gross profit: 579200000
Operating income: 172239000
Net income: 226349000
Capital expenditures: 103946000
Operating cash flow: 45955000
Depreciation & amortization: 122429000
Net tangible assets: 727489000
Owner earnings: 244832000
Return on net tangible assets (%): 33.65439202517152
Capex to operating income (%): 60.34986269079593
Buffett classification: The Good
Stock price: 107.72
P/E ratio: 143.90961314194794
Shares outstanding: 195639321
Book value: 8687415000
P/B ratio: 2.4258387170544977
Market cap (USD): 21074267658.12
Debt to equity: 0.403555257806839
Current ratio: 2.3283486225320065
Quick ratio: 1.3878944109218163
Effective tax rate (%): -3.8315059524358417
Interest coverage ratio: 2.9331755249399705
COGS to revenue (%): 63.37371583517666
R&D to revenue (%): 9.793800090806878
SG&A to revenue (%): 15.94078076209483
Free cash flow (dilution-adjusted): -102125000
Buyback yield (%): 0
Retained earnings: 777244000
Inventory turnover: 0.6138520952710546
Receivables turnover: 1.4751068753772003
Capitalized R&D asset: 308963360
ROCI (R&D-adjusted, %): 1.3060265448259567
Rosenberg metric: 0.21222044574576696
FCF margin (%): -6.4579752595521125
Revenue growth (%): 3.3961538763308825
Rule of 40 score: -3.06182138322123
Financial ratios for COHR — quarterly report dated 2025-12-31
Total revenue: 1685629000
Gross profit: 622820000
Operating income: 198624000
Net income: 146717000
Capital expenditures: 153598000
Operating cash flow: 57900000
Depreciation & amortization: 126019000
Net tangible assets: 1012441000
Owner earnings: 119138000
Return on net tangible assets (%): 11.76740175476892
Capex to operating income (%): 77.33103753826325
Buffett classification: The Gruesome
Stock price: 184.57
P/E ratio: 123.17299707655938
Shares outstanding: 195639321
Book value: 8888284000
P/B ratio: 4.062555773079483
Market cap (USD): 36109149476.97
Debt to equity: 0.39901121521319527
Current ratio: 2.2517626062996645
Quick ratio: 1.3046464331695957
Effective tax rate (%): 14.39031359382813
Interest coverage ratio: 4.323834817249711
COGS to revenue (%): 63.05118148774137
R&D to revenue (%): 9.830632956599585
SG&A to revenue (%): 15.3348097357129
Free cash flow (dilution-adjusted): -138466000
Buyback yield (%): 0
Retained earnings: 922338000
Inventory turnover: 0.5751420390744773
Receivables turnover: 1.5342073383289478
Capitalized R&D asset: 320869460
ROCI (R&D-adjusted, %): 1.52745574479771
Rosenberg metric: 0.2816428520697069
FCF margin (%): -8.214500343788579
Revenue growth (%): 6.5924149697289325
Rule of 40 score: -1.6220853740596466
Financial ratios for CRAP.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 71.2840909090909
Shares outstanding: 674474
Market cap (USD): 48079265.93181818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRAP.PA — annual report dated 2022-12-31
Total revenue: 479122340.4255319
Net income: 154336170.21276596
Capital expenditures: 4670212.765957447
Operating cash flow: -1169196808.5106385
Depreciation & amortization: 17751063.829787236
Net tangible assets: 3129678723.4042554
Owner earnings: 167417021.27659574
Return on net tangible assets (%): 5.349335700965839
Buffett classification: The Gruesome
Stock price: 54.191489361702125
P/E ratio: 0.23682556425597617
Shares outstanding: 674474
Book value: 3129774468.085106
P/B ratio: 0.011678397586937813
Market cap (USD): 36550750.59574468
Debt to equity: 0.1547239485681111
Effective tax rate (%): 16.183675355888333
COGS to revenue (%): 0
SG&A to revenue (%): 19.160255342769915
Free cash flow (dilution-adjusted): -1173867021.2765958
Buyback yield (%): 0
Retained earnings: 154336170.21276596
Receivables turnover: 1.52689159959588
Capitalized R&D asset: 0
FCF margin (%): -245.00360810435748
Rule of 40 score: -245.00360810435748
Financial ratios for CRAP.PA — annual report dated 2023-12-31
Total revenue: 476508888.8888889
Net income: 129336666.66666666
Capital expenditures: 9036666.666666666
Operating cash flow: -698104444.4444444
Depreciation & amortization: 17315555.555555556
Net tangible assets: 3519558888.888889
Owner earnings: 137615555.55555555
Return on net tangible assets (%): 3.9100228153591217
Buffett classification: The Gruesome
Stock price: 68.58888888888889
P/E ratio: 0.3576821904933722
Shares outstanding: 674474
Book value: 3520227777.777775
P/B ratio: 0.013141599113693727
Market cap (USD): 46261422.244444445
Debt to equity: 0.22604155981068164
Effective tax rate (%): 14.545281024255594
COGS to revenue (%): 0
SG&A to revenue (%): 20.53733403597461
Free cash flow (dilution-adjusted): -707141111.111111
Buyback yield (%): 0
Retained earnings: 129335555.55555555
Receivables turnover: 1.3970044041383265
Capitalized R&D asset: 0
FCF margin (%): -148.40040293057376
Revenue growth (%): -0.5454664322940764
Rule of 40 score: -148.94586936286782
Financial ratios for CRAP.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3601651041.666667
Buffett classification: The Gruesome
Stock price: 80.60416666666667
Shares outstanding: 674474
Book value: 3602265625
P/B ratio: 0.015092006078350576
Market cap (USD): 54365414.708333336
Debt to equity: 0.20754386345398945
Buyback yield (%): 0
Retained earnings: 139510416.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRAP.PA — annual report dated 2024-12-31
Total revenue: 471436458.3333334
Net income: 139510416.6666667
Capital expenditures: 13754166.666666668
Operating cash flow: 229171875
Depreciation & amortization: 17795833.333333336
Net tangible assets: 3601651041.666667
Owner earnings: 143552083.33333337
Return on net tangible assets (%): 3.9857299242101067
Buffett classification: The Gruesome
Stock price: 80.60416666666667
P/E ratio: 0.38968713596654964
Shares outstanding: 674474
Book value: 3602265625
P/B ratio: 0.015092006078350576
Market cap (USD): 54365414.708333336
Debt to equity: 0.20754386345398945
Effective tax rate (%): 13.323539309844934
COGS to revenue (%): 0
SG&A to revenue (%): 19.2881242832743
Free cash flow (dilution-adjusted): 215417708.33333334
Buyback yield (%): 0
Retained earnings: 139510416.6666667
Receivables turnover: 1.5370682950520134
Capitalized R&D asset: 0
FCF margin (%): 45.693900954308525
Revenue growth (%): -1.064498621921468
Rule of 40 score: 44.62940233238706
Financial ratios for CRAP.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 4300181176.470589
Buffett classification: The Gruesome
Stock price: 107.5294117647059
Shares outstanding: 674474
Book value: 4300903529.411766
P/B ratio: 0.01686292007589103
Market cap (USD): 72525792.47058825
Debt to equity: 0.10833455514682548
Buyback yield (%): 0
Retained earnings: 120291764.70588236
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 90893695
Market cap (USD): 234505733.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNT — annual report dated 2022-12-31
Total revenue: 83855965.9090909
Gross profit: 26438352.272727273
Operating income: -3107102.272727273
Net income: -5593465.909090909
Capital expenditures: 2972727.272727273
Operating cash flow: -1390625
Depreciation & amortization: 3136363.6363636362
Net tangible assets: 31697443.181818184
Owner earnings: -5429829.545454546
Return on net tangible assets (%): -17.130181492269774
Buffett classification: The Gruesome
Stock price: 1.91
Shares outstanding: 90893695
Book value: 34029261.36363637
P/B ratio: 5.101696319377541
Market cap (USD): 173606957.45
Debt to equity: 0.4544217459906664
Current ratio: 1.5865202204221747
Quick ratio: 1.0444307266102564
Interest coverage ratio: -2.180422647527911
COGS to revenue (%): 68.47170981085668
R&D to revenue (%): 10.058508061374178
SG&A to revenue (%): 23.7453967673195
Free cash flow (dilution-adjusted): -5930681.818181818
Buyback yield (%): 0
Retained earnings: -79945454.54545455
Inventory turnover: 2.8067324917718617
Receivables turnover: 2.70082349711776
Capitalized R&D asset: 8434659.090909092
ROCI (R&D-adjusted, %): 4.7570705225991725
FCF margin (%): -7.072462589735512
Rule of 40 score: -7.072462589735512
Financial ratios for CRNT — annual report dated 2023-12-31
Total revenue: 95905801.10497238
Gross profit: 33112983.425414365
Operating income: 6415745.856353591
Net income: 1718232.0441988949
Capital expenditures: 2750000
Operating cash flow: 8532320.44198895
Depreciation & amortization: 2753314.917127072
Net tangible assets: 30350552.486187845
Owner earnings: 1721546.9613259668
Return on net tangible assets (%): 5.672209631470205
Capex to operating income (%): 42.86329386437029
Buffett classification: The Good
Stock price: 2.16
P/E ratio: 114.26301928360131
Shares outstanding: 90893695
Book value: 37021823.204419896
P/B ratio: 5.303098664696797
Market cap (USD): 196330381.20000002
Debt to equity: 0.3746110626105253
Current ratio: 1.6392258918565208
Quick ratio: 1.1216670552751724
Effective tax rate (%): 51.185057290849166
Interest coverage ratio: 3.0810559830193687
COGS to revenue (%): 65.4734301325829
R&D to revenue (%): 9.296069174690864
SG&A to revenue (%): 18.54086796724456
Free cash flow (dilution-adjusted): 3874033.149171271
Buyback yield (%): 0
Retained earnings: -76018784.53038673
Inventory turnover: 3.3033962593190043
Receivables turnover: 3.049415464071462
Capitalized R&D asset: 14566691.20416876
ROCI (R&D-adjusted, %): 15.832632254896465
Rosenberg metric: 0.7913338382438047
FCF margin (%): 4.039414826357586
Revenue growth (%): 14.369681471375356
Rule of 40 score: 18.409096297732944
Financial ratios for CRNT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.74
Shares outstanding: 90893695
Market cap (USD): 249048724.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.67
Shares outstanding: 90893695
Market cap (USD): 424473555.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNT — annual report dated 2024-12-31
Total revenue: 107997260.2739726
Gross profit: 37493424.65753425
Operating income: 11452876.712328767
Net income: 6592602.7397260275
Capital expenditures: 3994794.5205479455
Operating cash flow: 7177534.2465753425
Depreciation & amortization: 3318356.164383562
Net tangible assets: 38845205.47945206
Owner earnings: 5916164.383561645
Return on net tangible assets (%): 15.230101914871108
Capex to operating income (%): 34.880271750831284
Buffett classification: The Good
Stock price: 4.67
P/E ratio: 64.38633911492748
Shares outstanding: 90893695
Book value: 45568493.15068493
P/B ratio: 9.315066755583947
Market cap (USD): 424473555.65
Debt to equity: 0.24714865474222156
Current ratio: 1.7236147060377158
Quick ratio: 1.3294662194284506
Effective tax rate (%): 11.705133379811397
Interest coverage ratio: 6.997489119517911
COGS to revenue (%): 65.2829853623887
R&D to revenue (%): 8.866536441817399
SG&A to revenue (%): 14.95141936629544
Free cash flow (dilution-adjusted): 1489315.0684931506
Buyback yield (%): 0
Retained earnings: -68801369.8630137
Inventory turnover: 4.3110414956527565
Receivables turnover: 2.474886360782541
Capitalized R&D asset: 18332418.579240143
ROCI (R&D-adjusted, %): 16.890931094886714
Rosenberg metric: 0.4913303978519546
FCF margin (%): 1.3790304168040792
Revenue growth (%): 12.607641070393317
Rule of 40 score: 13.986671487197397
Financial ratios for CRNT — quarterly report dated 2025-03-31
Total revenue: 24024932.249322493
Gross profit: 7885907.859078591
Operating income: 844715.4471544715
Net income: -265582.65582655824
Capital expenditures: 940108.4010840108
Operating cash flow: 707317.0731707318
Depreciation & amortization: 902981.0298102981
Net tangible assets: 36224390.24390244
Owner earnings: -302710.02710027096
Return on net tangible assets (%): -0.8356525121943921
Capex to operating income (%): 111.29290984921398
Buffett classification: The Gruesome
Stock price: 2.35
Shares outstanding: 90893695
Book value: 45259349.593495935
P/B ratio: 4.719470897582138
Market cap (USD): 213600183.25
Debt to equity: 0.24412749166202616
Current ratio: 1.6855322089762503
Quick ratio: 1.2712544688542458
COGS to revenue (%): 67.17614943825295
R&D to revenue (%): 9.304922618779047
SG&A to revenue (%): 20.00293281595452
Free cash flow (dilution-adjusted): -554742.5474254743
Buyback yield (%): 0
Retained earnings: -68321138.21138212
Inventory turnover: 0.9552475819257975
Receivables turnover: 0.5418230268063415
Capitalized R&D asset: 2235501.3550135503
ROCI (R&D-adjusted, %): 4.224894005812111
FCF margin (%): -2.3090285611153725
Rule of 40 score: -2.3090285611153725
Financial ratios for CRNT — quarterly report dated 2025-06-30
Total revenue: 24266076.69616519
Gross profit: 8389380.530973451
Operating income: 721533.9233038347
Net income: -373746.3126843658
Capital expenditures: 1167256.6371681415
Operating cash flow: 3174631.268436578
Depreciation & amortization: 1071386.430678466
Net tangible assets: 40799410.029498525
Owner earnings: -469616.5191740412
Return on net tangible assets (%): -1.1510375244017061
Capex to operating income (%): 161.77432542927227
Buffett classification: The Gruesome
Stock price: 2.46
Shares outstanding: 90893695
Book value: 50671681.415929206
P/B ratio: 4.4126913386716495
Market cap (USD): 223598489.7
Debt to equity: 0.21860318901832024
Current ratio: 1.860763516466055
Quick ratio: 1.384507210106066
Interest coverage ratio: 0.8446132596685082
COGS to revenue (%): 65.42753640806205
R&D to revenue (%): 8.912985339524933
SG&A to revenue (%): 22.686051883007952
Free cash flow (dilution-adjusted): 1204424.7787610618
Buyback yield (%): 0
Retained earnings: -74741002.94985251
Inventory turnover: 0.8978713465901508
Receivables turnover: 0.5671481264435174
Capitalized R&D asset: 3660617.766266159
ROCI (R&D-adjusted, %): 2.23695844356402
Rosenberg metric: 0.22521689408316584
FCF margin (%): 4.963409593737085
Revenue growth (%): 1.0037258142507222
Rule of 40 score: 5.967135407987807
Financial ratios for CRNT — quarterly report dated 2025-09-30
Total revenue: 25825981.87311178
Gross profit: 8867069.486404834
Operating income: 1139879.15407855
Net income: 8459.214501510574
Capital expenditures: 951661.6314199396
Operating cash flow: 2163444.108761329
Depreciation & amortization: 1038066.4652567976
Net tangible assets: 41815407.854984894
Owner earnings: 94864.04833836865
Return on net tangible assets (%): 0.22686386000910364
Capex to operating income (%): 83.48794063079777
Buffett classification: The Gruesome
Stock price: 2.33
P/E ratio: 6258.923606683035
Shares outstanding: 90893695
Book value: 51998187.31117825
P/B ratio: 4.072878696378563
Market cap (USD): 211782309.35
Debt to equity: 0.2766422255017023
Current ratio: 1.8142681047765792
Quick ratio: 1.3641910631741136
Effective tax rate (%): 96.3963963963964
Interest coverage ratio: 1.2678091397849465
COGS to revenue (%): 65.66608956061954
R&D to revenue (%): 8.136025455055918
SG&A to revenue (%): 21.784193533292783
Free cash flow (dilution-adjusted): 660120.8459214501
Buyback yield (%): 0
Retained earnings: -76538972.80966768
Inventory turnover: 0.9608695652173912
Receivables turnover: 0.6375358914121638
Capitalized R&D asset: 4288021.251501717
ROCI (R&D-adjusted, %): 1.6831980485130866
Rosenberg metric: 0.22086273307588497
FCF margin (%): 2.5560338776847127
Revenue growth (%): 6.428336959773584
Rule of 40 score: 8.984370837458297
Financial ratios for CRNT — quarterly report dated 2025-12-31
Total revenue: 25889937.106918238
Gross profit: 8699056.603773585
Operating income: 538993.7106918239
Net income: 40566.03773584905
Capital expenditures: 953773.5849056604
Operating cash flow: 3466352.2012578617
Depreciation & amortization: 1234905.6603773583
Net tangible assets: 43573270.44025157
Owner earnings: 321698.1132075471
Return on net tangible assets (%): 0.7382923291210496
Capex to operating income (%): 176.95449241540257
Buffett classification: The Gruesome
Stock price: 2.1
P/E ratio: 1176.3335178488373
Shares outstanding: 90893695
Book value: 54324528.30188679
P/B ratio: 3.513638598742707
Market cap (USD): 190876759.5
Debt to equity: 0.21031304992127442
Current ratio: 1.8731566120754906
Quick ratio: 1.36090062964226
Effective tax rate (%): 81.83098591549295
COGS to revenue (%): 66.39985424511113
R&D to revenue (%): 9.584598566743594
SG&A to revenue (%): 21.933681525567838
Free cash flow (dilution-adjusted): 1829245.2830188677
Buyback yield (%): 0
Retained earnings: -79627358.49056603
Inventory turnover: 0.887638625034504
Receivables turnover: 0.7255406524842695
Capitalized R&D asset: 4602990.721828556
ROCI (R&D-adjusted, %): 1.160915008403752
Rosenberg metric: -0.07996012099344882
FCF margin (%): 7.065468237580469
Revenue growth (%): 0.247639118313806
Rule of 40 score: 7.313107355894275
Financial ratios for CRNT — annual report dated 2025-12-31
Total revenue: 106518238.99371068
Gross profit: 36022641.50943396
Operating income: 3474842.767295597
Net income: -657232.7044025157
Capital expenditures: 4279559.748427672
Operating cash flow: 9923270.440251572
Depreciation & amortization: 4505345.911949685
Net tangible assets: 43573270.44025157
Owner earnings: -431446.54088050313
Return on net tangible assets (%): -0.9901633192121996
Capex to operating income (%): 123.15837104072398
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 90893695
Book value: 54324528.30188679
P/B ratio: 3.513638598742707
Market cap (USD): 190876759.5
Debt to equity: 0.21031304992127442
Current ratio: 1.8731566120754906
Quick ratio: 1.36090062964226
Effective tax rate (%): 395.1977401129943
Interest coverage ratio: 2.195073500198649
COGS to revenue (%): 66.18171512245814
R&D to revenue (%): 8.982723601237572
SG&A to revenue (%): 21.573356793651545
Free cash flow (dilution-adjusted): 3156603.7735849055
Buyback yield (%): 0
Retained earnings: -79627358.49056603
Inventory turnover: 3.639988958708819
Receivables turnover: 2.985071470116502
Capitalized R&D asset: 18926006.979785014
ROCI (R&D-adjusted, %): 4.565808968532519
Rosenberg metric: -0.15359670654819738
FCF margin (%): 2.9634396920242794
Revenue growth (%): -1.369498889610595
Rule of 40 score: 1.5939408024136843
Financial ratios for CTUK.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.036351351351351355
Shares outstanding: 93555470
Market cap (USD): 3400867.760810811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTUK.L — annual report dated 2022-09-30
Total revenue: -49404444.44444444
Net income: -50306666.666666664
Capital expenditures: 0
Operating cash flow: 12805555.555555556
Net tangible assets: 329203333.3333333
Owner earnings: -50306666.666666664
Return on net tangible assets (%): -15.28133574994178
Buffett classification: The Gruesome
Stock price: 0.026777777777777775
Shares outstanding: 93555470
Book value: 329203333.3333334
P/B ratio: 0.007609909535815418
Market cap (USD): 2505207.5855555553
Debt to equity: 0.08100363503812232
Free cash flow (dilution-adjusted): 12805555.555555556
Buyback yield (%): 0
Receivables turnover: -8.883916083916084
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTUK.L — annual report dated 2023-09-30
Total revenue: 47795121.951219514
Net income: 46735365.85365854
Capital expenditures: 0
Operating cash flow: 15131707.317073172
Net tangible assets: 383837804.8780488
Owner earnings: 46735365.85365854
Return on net tangible assets (%): 12.175811048238746
Buffett classification: The Gruesome
Stock price: 0.0325609756097561
P/E ratio: 0.06518098919708791
Shares outstanding: 93555470
Book value: 383837804.8780488
P/B ratio: 0.007936314084010333
Market cap (USD): 3046257.3768292684
Debt to equity: 0.07942887461993284
Effective tax rate (%): 0.05737384274351285
COGS to revenue (%): 0
SG&A to revenue (%): 2.1356399265156156
Free cash flow (dilution-adjusted): 15131707.317073172
Buyback yield (%): 0
Receivables turnover: 14.392948953360264
Capitalized R&D asset: 0
FCF margin (%): 31.659522351500307
Rule of 40 score: 31.659522351500307
Financial ratios for CTUK.L — annual report dated 2024-09-30
Total revenue: 75305333.33333333
Net income: 74070666.66666667
Capital expenditures: 0
Operating cash flow: 13756000
Net tangible assets: 458658666.6666667
Owner earnings: 74070666.66666667
Return on net tangible assets (%): 16.14940958272528
Buffett classification: The Gruesome
Stock price: 0.041600000000000005
P/E ratio: 0.05254316893777114
Shares outstanding: 93555470
Book value: 458658666.6666667
P/B ratio: 0.008485411559503947
Market cap (USD): 3891907.5520000006
Debt to equity: 0.08139676854828863
Effective tax rate (%): 0.050376927367265796
COGS to revenue (%): 0
SG&A to revenue (%): 1.558101241169284
Free cash flow (dilution-adjusted): 13756000
Buyback yield (%): 0
Receivables turnover: 47.105087572977475
Capitalized R&D asset: 0
FCF margin (%): 18.26696648311762
Revenue growth (%): 57.558617404912546
Rule of 40 score: 75.82558388803017
Financial ratios for CTUK.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 458658666.6666667
Buffett classification: The Gruesome
Stock price: 0.041600000000000005
Shares outstanding: 93555470
Book value: 458658666.6666667
P/B ratio: 0.008485411559503947
Market cap (USD): 3891907.5520000006
Debt to equity: 0.08139676854828863
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTUK.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 423920779.22077924
Buffett classification: The Gruesome
Stock price: 0.039350649350649344
Shares outstanding: 93555470
Book value: 423920779.2207792
P/B ratio: 0.008684331307307478
Market cap (USD): 3681468.4948051944
Debt to equity: 0.06127094317426376
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTUK.L — annual report dated 2025-09-30
Total revenue: 26890540.540540542
Net income: 25498648.64864865
Capital expenditures: 0
Operating cash flow: 14428378.378378378
Net tangible assets: 454485135.1351351
Owner earnings: 25498648.64864865
Return on net tangible assets (%): 5.610447224212727
Buffett classification: The Gruesome
Stock price: 0.04418918918918919
P/E ratio: 0.16213174354761775
Shares outstanding: 93555470
Book value: 454485135.1351352
P/B ratio: 0.009096315905435018
Market cap (USD): 4134140.3635135135
Debt to equity: 0.04460051320323859
Effective tax rate (%): 0.20098376262759823
COGS to revenue (%): 0
SG&A to revenue (%): 4.9148198401929735
Free cash flow (dilution-adjusted): 14428378.378378378
Buyback yield (%): 0
Receivables turnover: 18.373961218836566
Capitalized R&D asset: 0
FCF margin (%): 53.65596261118649
Revenue growth (%): -64.29131995006036
Rule of 40 score: -10.635357338873867
Financial ratios for CTUK.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 454485135.1351351
Buffett classification: The Gruesome
Stock price: 0.04418918918918919
Shares outstanding: 93555470
Book value: 454485135.1351352
P/B ratio: 0.009096315905435018
Market cap (USD): 4134140.3635135135
Debt to equity: 0.04460051320323859
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELUT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.3
Shares outstanding: 44208236
Market cap (USD): 278511886.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELUT — annual report dated 2022-12-31
Total revenue: 23849000
Gross profit: 11639000
Operating income: -29989000
Net income: -32897000
Capital expenditures: 540000
Operating cash flow: -21434000
Depreciation & amortization: 3733000
Net tangible assets: -20102000
Owner earnings: -29704000
Buffett classification: The Gruesome
Stock price: 4.25
Shares outstanding: 44208236
Book value: -5033000
Market cap (USD): 187885003
Debt to equity: -4.866282535267236
Current ratio: 1.1896984629825178
Quick ratio: 1.0902029801713011
Interest coverage ratio: -5.859515435717077
COGS to revenue (%): 51.19711518302654
R&D to revenue (%): 32.39968132835758
SG&A to revenue (%): 142.14851775755795
Free cash flow (dilution-adjusted): -25621000
Buyback yield (%): 0
Retained earnings: -137988000
Inventory turnover: 2.8797169811320753
Receivables turnover: 1.3560584522658783
Capitalized R&D asset: 7727000
ROCI (R&D-adjusted, %): -73.15308416536585
FCF margin (%): -107.43008092582498
Rule of 40 score: -107.43008092582498
Financial ratios for ELUT — annual report dated 2023-12-31
Total revenue: 24745000
Gross profit: 11053000
Operating income: -20537000
Net income: -37656000
Capital expenditures: 346000
Operating cash flow: -21761000
Depreciation & amortization: 3748000
Net tangible assets: -50271000
Owner earnings: -34254000
Buffett classification: The Gruesome
Stock price: 2.16
Shares outstanding: 44208236
Book value: -38600000
Market cap (USD): 95489789.76
Debt to equity: -0.6205181347150259
Current ratio: 0.7261890931059322
Quick ratio: 0.6366614773334572
Interest coverage ratio: -3.543305728088337
COGS to revenue (%): 55.33239038189534
R&D to revenue (%): 17.77732875328349
SG&A to revenue (%): 109.8848252172156
Free cash flow (dilution-adjusted): -24544000
Buyback yield (%): 0
Retained earnings: -175644000
Inventory turnover: 3.5535946016091358
Receivables turnover: 4.1525423728813555
Capitalized R&D asset: 9576090
ROCI (R&D-adjusted, %): -202.46631664808885
Rosenberg metric: -0.07583797075190889
FCF margin (%): -99.18771468983633
Revenue growth (%): 3.756970942177869
Rule of 40 score: -95.43074374765845
Financial ratios for ELUT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.81
Shares outstanding: 44208236
Market cap (USD): 168433379.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELUT — annual report dated 2024-12-31
Total revenue: 14467000
Gross profit: 6715000
Operating income: -19344000
Net income: -53949000
Capital expenditures: 654000
Operating cash flow: -22657000
Depreciation & amortization: 3451000
Net tangible assets: -48860000
Owner earnings: -51152000
Buffett classification: The Gruesome
Stock price: 3.74
Shares outstanding: 44208236
Book value: -46260000
Market cap (USD): 165338802.64000002
Debt to equity: -0.5191093817552962
Current ratio: 0.6924725492790051
Quick ratio: 0.6413811350707765
Interest coverage ratio: -21.493333333333332
COGS to revenue (%): 53.5840188014101
R&D to revenue (%): 20.723024815096426
SG&A to revenue (%): 159.4041611944425
Free cash flow (dilution-adjusted): -31202000
Buyback yield (%): 0
Retained earnings: -229593000
Inventory turnover: 4.014500258933195
Receivables turnover: 2.0561398521887435
Capitalized R&D asset: 8495240
ROCI (R&D-adjusted, %): -313.2647062844331
Rosenberg metric: -0.9861332120936577
FCF margin (%): -215.67705813230108
Revenue growth (%): -41.53566377045868
Rule of 40 score: -257.21272190275977
Financial ratios for ELUT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.74
Shares outstanding: 44208236
Market cap (USD): 165338802.64000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELUT — quarterly report dated 2025-03-31
Total revenue: 2951000
Gross profit: 1382000
Operating income: -4205000
Net income: -3933000
Capital expenditures: 278000
Operating cash flow: -8881000
Depreciation & amortization: 868000
Net tangible assets: -43882000
Owner earnings: -3343000
Buffett classification: The Gruesome
Stock price: 2.53
Shares outstanding: 44208236
Book value: -36458000
Market cap (USD): 111846837.08
Debt to equity: -0.6861594163146635
Current ratio: 0.8145504870966866
Quick ratio: 0.6982442810235815
Interest coverage ratio: -22.85326086956522
COGS to revenue (%): 53.168417485598106
R&D to revenue (%): 29.515418502202646
SG&A to revenue (%): 159.8102338190444
Free cash flow (dilution-adjusted): -10370000
Buyback yield (%): 0
Retained earnings: -233526000
Inventory turnover: 0.366075594960336
Receivables turnover: 0.43699096697763956
Capitalized R&D asset: 871000
ROCI (R&D-adjusted, %): -109.23246935905165
FCF margin (%): -351.40630294815315
Rule of 40 score: -351.40630294815315
Financial ratios for ELUT — quarterly report dated 2025-06-30
Total revenue: 6263000
Gross profit: 3058000
Operating income: -5871000
Net income: -9610000
Capital expenditures: 114000
Operating cash flow: -8228000
Depreciation & amortization: 892000
Net tangible assets: -48418000
Owner earnings: -8832000
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 44208236
Book value: -41843000
Market cap (USD): 87532307.28
Debt to equity: -0.6749277059484262
Current ratio: 0.587119215768947
Quick ratio: 0.44895646674396544
Interest coverage ratio: -11.333976833976834
COGS to revenue (%): 51.17355899728565
R&D to revenue (%): 23.24764489861089
SG&A to revenue (%): 119.31981478524669
Free cash flow (dilution-adjusted): -9491000
Buyback yield (%): 0
Retained earnings: -243136000
Inventory turnover: 0.6112912454701507
Receivables turnover: 0.8410098026050759
Capitalized R&D asset: 2039570
Rosenberg metric: 1.9242250287026406
FCF margin (%): -151.54079514609612
Revenue growth (%): 112.23314130803116
Rule of 40 score: -39.30765383806495
Financial ratios for ELUT — quarterly report dated 2025-09-30
Total revenue: 3323000
Gross profit: 1853000
Operating income: -4355000
Net income: -3868000
Capital expenditures: 630000
Operating cash flow: -2887000
Depreciation & amortization: 728000
Net tangible assets: -45718000
Owner earnings: -3770000
Buffett classification: The Gruesome
Stock price: 0.89
Shares outstanding: 44208236
Book value: -43918000
Market cap (USD): 39345330.04
Debt to equity: -0.6634864975636413
Current ratio: 0.4446218609377268
Quick ratio: 0.39596941984806694
Interest coverage ratio: -16.433962264150942
COGS to revenue (%): 44.237135118868494
R&D to revenue (%): 32.74149864580199
SG&A to revenue (%): 154.07764068612698
Free cash flow (dilution-adjusted): -5499000
Buyback yield (%): 0
Retained earnings: -247004000
Inventory turnover: 0.730979612133267
Receivables turnover: 0.409539068277052
Capitalized R&D asset: 2350950
Rosenberg metric: -0.8276098901098901
FCF margin (%): -165.48299729160397
Revenue growth (%): -46.94235989142583
Rule of 40 score: -212.4253571830298